Listings

In this section

Events

Awards

Buyer's Guides

02/24/2024 05:15:19
  • Home | Pathbreakers: The journey of first generics
  • Editor's letter
  • Contents
  • wek-tec Company Insight
  • Mimotopes Company Insight
  • Mimotopes
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Datwyler Company Insight
  • Datwyler
  • Veeva
  • In Depth
  • Pathbreakers: The journey of first generics
  • Managed access programmes: Reaching patients in need
  • Insulin pricing in flux as major pharma players take action
  • As RSV vaccine approvals loom, regulators need to devise vaccination strategies
  • Build API facilities in Central and Eastern Europe to fix drug shortages, says report
  • CfPIE
  • BEA Technologies
  • Thematic Take
  • Thematic Take: contents
  • Foreword
  • The state of cybersecurity in 2023
  • The history of cybersecurity
  • The impact of cybersecurity on the pharmaceutical industry
  • Case studies: cybersecurity in the pharmaceutical industry
  • Latest news: cybersecurity in pharma
  • Q&A with GlobalData thematic analyst
  • Key cybersecurity trends in Pharma
  • Cybersecurity in pharma: Securing the future
  • Deal activity related to cybersecurity in the pharmaceutical industry since 2018
  • Cybersecurity hiring trends in the global pharmaceutical industry since 2020
  • Cybersecurity patent applications in the global pharma industry since 2020
  • Mentions of cybersecurity in pharma industry company filings since 2020
  • GlobalData Thematic Intelligence
  • Sponsored Supplements
  • Listings
  • Events
  • Awards
  • Buyer's Guides
  • Next issue
06/05/2023 00:00:00